213 related articles for article (PubMed ID: 23997989)
1. Oncogenic Signaling by Leukemia-Associated Mutant Cbl Proteins.
Nadeau S; An W; Palermo N; Feng D; Ahmad G; Dong L; Borgstahl GE; Natarajan A; Naramura M; Band V; Band H
Biochem Anal Biochem; 2012 Jul; Suppl 6(1):. PubMed ID: 23997989
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases.
Mohapatra B; Ahmad G; Nadeau S; Zutshi N; An W; Scheffe S; Dong L; Feng D; Goetz B; Arya P; Bailey TA; Palermo N; Borgstahl GE; Natarajan A; Raja SM; Naramura M; Band V; Band H
Biochim Biophys Acta; 2013 Jan; 1833(1):122-39. PubMed ID: 23085373
[TBL] [Abstract][Full Text] [Related]
3. Indispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo models.
Naramura M; Band V; Band H
Commun Integr Biol; 2011 Mar; 4(2):159-62. PubMed ID: 21655429
[TBL] [Abstract][Full Text] [Related]
4. Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders.
Naramura M; Nadeau S; Mohapatra B; Ahmad G; Mukhopadhyay C; Sattler M; Raja SM; Natarajan A; Band V; Band H
Oncotarget; 2011 Mar; 2(3):245-50. PubMed ID: 21422499
[TBL] [Abstract][Full Text] [Related]
5. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Lv K; Jiang J; Donaghy R; Riling CR; Cheng Y; Chandra V; Rozenova K; An W; Mohapatra BC; Goetz BT; Pillai V; Han X; Todd EA; Jeschke GR; Langdon WY; Kumar S; Hexner EO; Band H; Tong W
Genes Dev; 2017 May; 31(10):1007-1023. PubMed ID: 28611190
[TBL] [Abstract][Full Text] [Related]
6. Structural Determinants of the Gain-of-Function Phenotype of Human Leukemia-associated Mutant CBL Oncogene.
Nadeau SA; An W; Mohapatra BC; Mushtaq I; Bielecki TA; Luan H; Zutshi N; Ahmad G; Storck MD; Sanada M; Ogawa S; Band V; Band H
J Biol Chem; 2017 Mar; 292(9):3666-3682. PubMed ID: 28082680
[TBL] [Abstract][Full Text] [Related]
7. CBL exon 8/9 mutants activate the FLT3 pathway and cluster in core binding factor/11q deletion acute myeloid leukemia/myelodysplastic syndrome subtypes.
Reindl C; Quentmeier H; Petropoulos K; Greif PA; Benthaus T; Argiropoulos B; Mellert G; Vempati S; Duyster J; Buske C; Bohlander SK; Humphries KR; Hiddemann W; Spiekermann K
Clin Cancer Res; 2009 Apr; 15(7):2238-47. PubMed ID: 19276253
[TBL] [Abstract][Full Text] [Related]
8. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
9. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
Makishima H; Cazzolli H; Szpurka H; Dunbar A; Tiu R; Huh J; Muramatsu H; O'Keefe C; Hsi E; Paquette RL; Kojima S; List AF; Sekeres MA; McDevitt MA; Maciejewski JP
J Clin Oncol; 2009 Dec; 27(36):6109-16. PubMed ID: 19901108
[TBL] [Abstract][Full Text] [Related]
10. Casitas B-lineage lymphoma linker helix mutations found in myeloproliferative neoplasms affect conformation.
Buetow L; Tria G; Ahmed SF; Hock A; Dou H; Sibbet GJ; Svergun DI; Huang DT
BMC Biol; 2016 Sep; 14(1):76. PubMed ID: 27609087
[TBL] [Abstract][Full Text] [Related]
11. Loss of Cbl and Cbl-b ubiquitin ligases abrogates hematopoietic stem cell quiescence and sensitizes leukemic disease to chemotherapy.
An W; Nadeau SA; Mohapatra BC; Feng D; Zutshi N; Storck MD; Arya P; Talmadge JE; Meza JL; Band V; Band H
Oncotarget; 2015 Apr; 6(12):10498-509. PubMed ID: 25871390
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
Sévère N; Dieudonné FX; Marie PJ
Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
[TBL] [Abstract][Full Text] [Related]
13. Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells.
Naramura M; Nandwani N; Gu H; Band V; Band H
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16274-9. PubMed ID: 20805496
[TBL] [Abstract][Full Text] [Related]
14. An essential role of ubiquitination in Cbl-mediated negative regulation of the Src-family kinase Fyn.
Rao N; Ghosh AK; Douillard P; Andoniou CE; Zhou P; Band H
Signal Transduct; 2002 Nov; 2(1-2):29-39. PubMed ID: 19966925
[TBL] [Abstract][Full Text] [Related]
15. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
Rao N; Dodge I; Band H
J Leukoc Biol; 2002 May; 71(5):753-63. PubMed ID: 11994499
[TBL] [Abstract][Full Text] [Related]
16. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
Sanada M; Suzuki T; Shih LY; Otsu M; Kato M; Yamazaki S; Tamura A; Honda H; Sakata-Yanagimoto M; Kumano K; Oda H; Yamagata T; Takita J; Gotoh N; Nakazaki K; Kawamata N; Onodera M; Nobuyoshi M; Hayashi Y; Harada H; Kurokawa M; Chiba S; Mori H; Ozawa K; Omine M; Hirai H; Nakauchi H; Koeffler HP; Ogawa S
Nature; 2009 Aug; 460(7257):904-8. PubMed ID: 19620960
[TBL] [Abstract][Full Text] [Related]
17. Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.
Taylor SJ; Thien CB; Dagger SA; Duyvestyn JM; Grove CS; Lee BH; Gilliland DG; Langdon WY
Exp Hematol; 2015 Mar; 43(3):191-206.e1. PubMed ID: 25534201
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
[TBL] [Abstract][Full Text] [Related]
19. Deregulated intracellular signaling by mutated c-CBL in myeloid neoplasms.
Ogawa S; Shih LY; Suzuki T; Otsu M; Nakauchi H; Koeffler HP; Sanada M
Clin Cancer Res; 2010 Aug; 16(15):3825-31. PubMed ID: 20547695
[TBL] [Abstract][Full Text] [Related]
20. Loss of function Cbl-c mutations in solid tumors.
Daniels SR; Liyasova M; Kales SC; Nau MM; Ryan PE; Green JE; Lipkowitz S
PLoS One; 2019; 14(7):e0219143. PubMed ID: 31260484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
